Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4C | Q9H3R0 | 16/20 | 0.55 |
| ▸ | KDM6B | O15054 | 7/20 | 0.55 |
| ▸ | KDM4D | Q6B0I6 | 4/20 | 0.55 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.55 |
| ▸ | KDM4A | O75164 | 2/20 | 0.55 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.55 |
| ▸ | MEN1 | O00255 | 1/20 | 0.55 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.55 |
| ▸ | MAPT | P10636 | 1/20 | 0.55 |
| ▸ | THRB | P10828 | 1/20 | 0.55 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.55 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.55 |
| ▸ | CA12 | O43570 | 1/20 | 0.50 |
| ▸ | CA1 | P00915 | 1/20 | 0.50 |
| ▸ | CA2 | P00918 | 1/20 | 0.50 |
| ▸ | CA9 | Q16790 | 1/20 | 0.50 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.50 |
| ▸ | SIRT3 | Q9NTG7 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19611328 | 1.00 | KDM4C (0.55) | KDM4CKDM6BKDM4DKDM4EKDM4A | |
| Acetone SCHEMBL2032550 | 0.94 | KDM4C (0.54) | KDM4CKDM6BKDM4DKDM4EKDM4A | |
| Acetone SCHEMBL15923153 | 0.93 | KDM4C (0.53) | KDM4CKDM6BKDM4DKDM4EKDM4A | |
| SCHEMBL1255875 | 0.88 | KDM4C (0.49) | KDM4CKDM6BKDM4DKDM4EKDM4A | |
| SCHEMBL12830011 | 0.86 | KDM4C (0.68) | KDM4CKDM6BKDM4DKDM4EKDM4A | |
| Succinimide SCHEMBL28021262 | 0.86 | KDM4C (0.43) | KDM4CKDM6BKDM4DKDM4EKDM4A | |
| SCHEMBL662028 | 0.84 | SIRT3 (0.58) | KDM4CKDM6BKDM4DKDM4EKDM4A | |
| SCHEMBL3823398 | 0.84 | KDM4C (0.76) | KDM4CKDM6BKDM4DKDM4EKDM4A | |
| SCHEMBL9616247 | 0.84 | KDM4C (0.55) | KDM4CKDM6BKDM4DKDM4EKDM4A | |
| SCHEMBL4654937 | 0.82 | CA12 (0.49) | KDM4CKDM6BKDM4DKDM4EKDM4A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 440 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250367305-A1 | ALBUMIN NANOCOMPOSITE COMPRISING PHYTOCHEMICAL AND COMPOSITION FOR IMPROVING MUSCLE DISEASE CONTAINING SAME | SEOUL NATIONAL UNIVERSITY R&DB FOUNDATION (KR) | 2025-12-04 | — | — | US | claimed |
| US-20250288704-A1 | CXCR4-LIGANDS FOR DIAGNOSTIC AND THERAPEUTIC USE AND PRECURSORS THEREOF | Technische Universität München (DE) | 2025-09-18 | — | — | US | claimed |
| US-20250276071-A1 | NANOPLATFORM FOR TARGETING INFLAMMATORY MACROPHAGES, AND COMPOSITION CONTAINING SAME FOR PREVENTING OR TREATING INFLAMMATORY DISEASES | CLICHEMBIO, INC (KR) | 2025-09-04 | — | — | US | claimed |
| EP-4585209-A1 | NANOPLATFORM FOR TARGETING INFLAMMATORY MACROPHAGES, AND COMPOSITION CONTAINING SAME FOR PREVENTING OR TREATING INFLAMMATORY DISEASES | Clichembio, Inc. (KR) | 2025-07-16 | — | — | EP | claimed |
| US-12208146-B2 | Reconstituted HDL nanoparticles for delivery of radioactive agents and uses thereof | UNIVERSITY OF NORTH TEXAS HEALTH SCIENCE CENTER (US) | 2025-01-28 | — | — | US | claimed |
| US-20250019402-A1 | PHARMACOKINETICS AND CHOLECYSTOKININ-2 RECEPTOR (CCK2R) TARGETING FOR DIAGNOSIS AND THERAPY | MEDIZINISCHE UNIV INNSBRUCK (AT) | 2025-01-16 | — | — | US | claimed |
| US-20240317780-A1 | RADIOPHARMACEUTICAL SOMATOSTATIN RECEPTOR LIGANDS AND PRECURSORS THEREOF | Technische Universität München (DE) | 2024-09-26 | — | — | US | claimed |
| WO-2024177490-A1 | ALBUMIN NANOCOMPOSITE COMPRISING PHYTOCHEMICAL AND COMPOSITION FOR IMPROVING MUSCLE DISEASE CONTAINING SAME | 서울대학교산학협력단 | 2024-08-29 | — | — | WO | claimed |
| US-20240199722-A1 | NANOPLATFORM FOR TARGETING MACROPHAGE AND COMPOSITION FOR PREVENTION OR TREATMENT OF METASTATIC CANCER | SEOUL NATIONAL UNIVERSITY R&DB FOUNDATION (KR) | 2024-06-20 | — | — | US | claimed |
| WO-2024112181-A1 | NANOPLATFORM FOR TARGETING INFLAMMATORY MACROPHAGES, AND COMPOSITION CONTAINING SAME FOR PREVENTING OR TREATING INFLAMMATORY DISEASES | (주)클리켐바이오 | 2024-05-30 | — | — | WO | claimed |
| WO-2016046793-A2 | RADIOPHARMACEUTICAL CONJUGATE | THE SOUTH AFRICAN NUCLEAR ENERGY CORPORATION LIMITED (ZA) | 2016-03-31 | — | — | WO | claimed |
| EP-1934251-B1 | INTERLEUKIN-8 LABELLED VIA ONE OR MORE SITE SPECIFICALLY CONJUGATED HYDRAZINONICOTINAMIDE (HYNIC) MOIETIES AND ITS USE IN DIAGNOSIS OF INFECTION AND INFLAMMATION | STICHTING KATHOLIEKE UNIV (NL) | 2010-06-16 | — | — | EP | claimed |
| US-20080233084-A1 | Interleukin-8 Labelled Via One or More Site Specifically Conjugated Hydrazinonicotinamide (Hynic) Moieties and its Use in Diagnosis of Infection and Inflammation | STICHTING KATHOLIEKE UNIVERSITEIT OF NIJMEGEN (NL) | 2008-09-25 | — | — | US | claimed |
| EP-1934251-A2 | INTERLEUKIN-8 LABELLED VIA ONE OR MORE SITE SPECIFICALLY CONJUGATED HYDRAZINONICOTINAMIDE (HYNIC) MOIETIES AND ITS USE IN DIAGNOSIS OF INFECTION AND INFLAMMATION | Stichting Katholieke Universiteit (NL) | 2008-06-25 | — | — | EP | claimed |
| US-20070258893-A1 | Compositions and methods for imaging expression of cell surface receptors | SEOUL NATIONAL UNIVERSITY INDUSTRY FOUNDATION (KP) | 2007-11-08 | — | — | US | claimed |
| WO-2007042946-A2 | INTERLEUKIN-8 LABELLED VIA ONE OR MORE SITE SPECIFICALLY CONJUGATED HYDRAZINONICOTINAMIDE (HYNIC) MOIETIES AND ITS USE IN DIAGNOSIS OF INFECTION AND INFLAMMATION | STICHTING KATHOLIEKE UNIVERSITEIT (NL) | 2007-04-19 | — | — | WO | claimed |
| EP-0869821-B1 | STEREOISOMERS OF FATTY ACID ANALOGS FOR DIAGNOSTIC IMAGING | MOLECULAR INSIGHT PHARM INC (US) | 2007-01-31 | — | — | EP | claimed |
| EP-0869820-B1 | CARDIOVASCULAR AND THROMBUS IMAGING AGENTS, METHODS AND KITS | GEN HOSPITAL CORP (US) | 2005-03-09 | — | — | EP | claimed |
| EP-0975373-B1 | RADIONUCLIDE ASSOCIATED WITH NUCLEOTIDE POLYPHOSPHATE AS TUMOR IMAGING AGENTS | GEN HOSPITAL CORP (US) | 2005-01-26 | — | — | EP | claimed |
| US-6491893-B1 | ADMINISTERING COLONY STIMULATING FACTORS AND RADIONUCLIDE LABELS, THEN DETECTING USING TOMOGRAPHY OR MAGNETIC RESONANCE IMAGING | BIOSTREAM, INC. | 2002-12-10 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240199722-A1 | NANOPLATFORM FOR TARGETING MACROPHAGE AND COMPOSITION FOR PREVENTION OR TREATMENT OF METASTATIC CANCER | SIGLEC9, B3GNT2, NEU3 | KDM4C 3780/4885KDM6B 4072/4885KDM4D 2941/4885 |
| US-20250276071-A1 | NANOPLATFORM FOR TARGETING INFLAMMATORY MACROPHAGES, AND COMPOSITION CONTAINING SAME FOR PREVENTING OR TREATING INFLAMMATORY DISEASES | GLS, TNF, ARG2 | KDM4C 3733/4885KDM6B 2564/4885KDM4D 4193/4885 |
| US-20250288704-A1 | CXCR4-LIGANDS FOR DIAGNOSTIC AND THERAPEUTIC USE AND PRECURSORS THEREOF | CXCR4, CXCR1, CXCR3 | KDM4C 4231/4885KDM6B 4771/4885KDM4D 4083/4885 |
| US-20240317780-A1 | RADIOPHARMACEUTICAL SOMATOSTATIN RECEPTOR LIGANDS AND PRECURSORS THEREOF | SSTR1, SSTR3, SSTR4 | KDM4C 4480/4885KDM6B 4276/4885KDM4D 4372/4885 |
| US-20250367305-A1 | ALBUMIN NANOCOMPOSITE COMPRISING PHYTOCHEMICAL AND COMPOSITION FOR IMPROVING MUSCLE DISEASE CONTAINING SAME | ALB, TNNC1, MYOF | KDM4C 3770/4885KDM6B 2814/4885KDM4D 3838/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.